Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (2)
  • 2024 (1)
  • 2023 (3)
  • 2022 (2)
  • 2021 (1)

Subject

  • Drug Trafficking (39)
  • Arrests/Convictions - Major (5)
  • Guilty Plea (5)
  • OCDETF/Task Force (5)
  • Pharmaceuticals/Pharmacists/Physicians (4)
  • Take Back Day (3)
  • Guns/Weapons (2)
  • Prescription Drugs (2)
  • Fake Pills (1)
  • Major Law Enforcement Operation (1)
  • Overdose (1)
  • Diversion Division (3)

Drug Name

  • Opioids (1)

Field Division

  • New York (11)
  • Chicago (8)
  • Washington, DC (8)
  • Houston (7)
  • New England (7)
  • Atlanta (5)
  • Seattle (5)
  • New Jersey (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • San Francisco (2)
  • St. Louis (2)
  • Dallas (1)
  • Louisville (1)
  • Phoenix (1)
  • Sede (1)
  • Miami (3)
Clear All Results
PRESS RELEASE

Christian & Missionary Alliance Foundation, Inc. Agrees to Pay $250,000 to Resolve Alleged Violations of the Controlled Substances Act

Agosto 03, 2023
FORT MYERS, Fla. - United States Attorney Roger Handberg announced that the Christian & Missionary Alliance Foundation, Inc. has agreed to pay the United States $250,000 to resolve allegations that the Christian & Missionary Alliance Foundation, Inc. violated the Controlled Substances Act (CSA) by failing to maintain records required by...
Agosto 03, 2023
PRESS RELEASE

Panama City Physician Pays $225,000 to Settle Allegations that He Overprescribed Controlled Substances

Marzo 21, 2023
PENSACOLA, Fla. – Dr. George Barrio, a pain management physician who formerly practiced medicine at the NeuroMedical Institute in Panama City, agreed to pay $225,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients. The settlement was announced by Jason R. Coody, United States Attorney...
Marzo 21, 2023
PRESS RELEASE

Physician Agrees to $190,731 Settlement Relating to Controlled Substances Act Claims

Febrero 24, 2023
PENSACOLA, Fla. – Timothy Ramsden, of Panama City, Florida, practicing at The Anti-Aging Clinic of Northwest Florida, settled potential violations of the Controlled Substances Act by agreeing to pay a fine of $190,731 and surrendering his Drug Enforcement Administration (DEA) registration for Schedule II and IIN controlled substances for a...
Febrero 24, 2023
Showing 1 - 3 of 3 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster